Triple Giving November OMF logo

 TRIPLE YOUR IMPACT during Triple Giving November | All Donations to OMF are TRIPLED through December 3

Search
Close this search box.

Characterizing B cells in ME/CFS

This study aims to broadly evaluate B cell subsets, metabolism, viability, receptors, and antibodies in people with ME/CFS.

  • Christopher Armstrong, PhD
  • Paul Gooley, PhD
  • Jo Cambridge, PhD
  • Ben Wendel, PhD

B cells secrete antibodies and are a major part of the adaptive immune system. Anomalies in B cell metabolism, CD markers and antibodies have been observed in ME/CFS. This may be due to something inherently disruptive within the B cells themselves.

Preliminary studies using immunoadsorption and/or plasmapheresis to remove the antibodies show positive effects in at least a subpopulation of ME/CFS patients.

STUDY HYPOTHESIS AND DESCRIPTION

A number of anomalies in B cells have been observed in the few studies conducted on ME/CFS patients. We want to expand this area of research to better understand these changes and determine if there are any potential anomalies in antibody production or metabolism that could be driving altered immune response.

OBJECTIVES

There are several studies involved in this multi-site collaborative effort:

  • Monitoring metabolism and CD marker changes in fresh ME/CFS B cells compared to healthy B cells during proliferative (via activation) and non-proliferative periods.
  • Monitoring metabolism changes in immortalized B cells from ME/CFS and healthy controls during proliferation.
  • Observing B cell subsets and antibodies in bone marrow from ME/CFS patients compared to healthy and disease controls.
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.


How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669